Eric M Bercaw
2PUBLICATIONS
3CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Sep 18, 2024
Estimation of the Eligible Population For Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis.Jesse Fishman, Yestle Kim, Michael R Charlton
|Aug 19, 2024
Budget impact of resmetirom for the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis).Jesse Fishman, Yestle Kim, Hélène Parisé
Pageof 1

